SAN JOSE, CA, Neuspera Medical, a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation System, announced a $23 Million Series D financing round.
Neuspera Medical, a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation System, announced a $23 Million Series D financing round led by Vertex Ventures HC and Treo Ventures with participation from Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
